Document Detail

Acute coronary syndrome associated with myocardial bridging due to ergotamine treatment for migraine.
MedLine Citation:
PMID:  16887217     Owner:  NLM     Status:  MEDLINE    
A 48-year-old woman presented with acute coronary syndrome and underwent coronary angiography which revealed myocardial bridging at the distal end of the left anterior descending artery with otherwise normal coronary arteries. The patient used to take ergotamine for her chronic migraine. Possible association with myocardial bridging which was found in this patient is discussed.
Avi Shimony; Ayal Romem; Sharon Horowitz; Raphael Boehm; Jacob Horowitz
Related Documents :
17321617 - Myotomy through heart-port access for myocardial bridging.
18180667 - Nsaids-induced anaphylaxis precipitating acute coronary vasospasm.
6138377 - Alpha-adrenergic blockade in vasotonic angina: lack of efficacy of specific alpha 1-rec...
7486217 - Acute myocardial infarction in a patient with primary coronary dissection and severe co...
2914477 - Acute ventricular septal rupture. angiographic-morphologic features and clinical assess...
15655127 - Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting...
Publication Detail:
Type:  Case Reports; Letter     Date:  2006-08-02
Journal Detail:
Title:  International journal of cardiology     Volume:  113     ISSN:  1874-1754     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  2006 Oct 
Date Detail:
Created Date:  2006-11-06     Completed Date:  2007-01-04     Revised Date:  2010-05-10    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  E7-8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Disease
Coronary Disease / chemically induced*
Coronary Vessel Anomalies / complications*
Ergotamine / adverse effects*,  therapeutic use
Middle Aged
Migraine Disorders / complications*,  drug therapy*
Vasoconstrictor Agents / adverse effects*,  therapeutic use
Reg. No./Substance:
0/Vasoconstrictor Agents; 113-15-5/Ergotamine
Comment In:
Int J Cardiol. 2010 May 14;141(1):111-4   [PMID:  19135734 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Urotensin II is raised in acute myocardial infarction and low levels predict risk of adverse clinica...
Next Document:  Intracoronary air embolism in open heart surgery--an uncommon source of myocardial ischaemia.